No photo of Dennis McCarty

View Scopus Profile

Dennis McCarty

Professor

  • 4030 Citations
  • 31 h-Index
1980 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dennis McCarty is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Substance-Related Disorders Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Alcohols Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Alcoholism Medicine & Life Sciences
Buprenorphine Medicine & Life Sciences
Medicaid Medicine & Life Sciences
Research Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

California-Arizona Clinical Trials Network Node

Sorensen, J. L., McCarty, D. & Korthuis, P. (.

National Institutes of Health

9/30/02 → 5/31/20

Project: Research project

Substance-Related Disorders
Clinical Trials
Research
Opiate Alkaloids
Research Personnel

OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK

McCarty, D. & Greenlick, M.

National Institutes of Health

9/30/99 → 8/31/11

Project: Research project

Clinical Trials
Substance-Related Disorders
Research
Behavioral Medicine
Therapeutics

Research Output 1980 2019

A changing landscape for treatment of alcohol and drug use disorders

McCarty, D., Jun 1 2019, In : American journal of public health. 109, 6, p. 838-839 2 p.

Research output: Contribution to journal › Editorial

Substance-Related Disorders
Alcohols
2 Citations (Scopus)

Barriers to Buprenorphine Expansion in Ohio: A Time-Elapsed Qualitative Study

Molfenter, T., Fitzgerald, M., Jacobson, N., McCarty, D., Quanbeck, A. & Zehner, M., Jan 1 2019, In : Journal of psychoactive drugs.

Research output: Contribution to journal › Article

Open Access
Buprenorphine
Opioid Analgesics
Substance-Related Disorders
Health Services Misuse
Interviews
2 Citations (Scopus)

Comparing Canadian and United States opioid agonist therapy policies

Priest, K. C., Gorfinkel, L., Klimas, J., Jones, A. A., Fairbairn, N. & McCarty, D., Jan 1 2019, In : International Journal of Drug Policy.

Research output: Contribution to journal › Article

Opioid Analgesics
Therapeutics
British Columbia
Canada
Buprenorphine
2 Citations (Scopus)

Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014–2015

Weisner, C., Campbell, C. I., Altschuler, A., Yarborough, B. J. H., Lapham, G. T., Binswanger, I. A., Hechter, R. C., Ahmedani, B. K., Haller, I. V., Sterling, S. A., McCarty, D., Satre, D. D. & Kline-Simon, A. H., Jan 1 2019, (Accepted/In press) In : Substance Abuse.

Research output: Contribution to journal › Article

Odds Ratio
Alcohols
Confidence Intervals
Delivery of Health Care
Pharmaceutical Preparations

Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis

Campbell, A. N. C., McCarty, D., Rieckmann, T., McNeely, J., Rotrosen, J., Wu, L. T. & Bart, G., Feb 1 2019, In : Journal of Substance Abuse Treatment. 97, p. 41-46 6 p.

Research output: Contribution to journal › Article

Privacy
Health
Interviews
Technology
Substance-Related Disorders